Rong Guo

Active 1997–2025

383
Papers
24,518
Citations
81
h-index
308
i10-index

Citations

Citations per year for Rong Guo1979: 1 citations1991: 1 citations1997: 3 citations1998: 11 citations1999: 3 citations2000: 9 citations2001: 16 citations2002: 22 citations2003: 45 citations2004: 43 citations2005: 45 citations2006: 31 citations2007: 61 citations2008: 65 citations2009: 94 citations2010: 121 citations2011: 103 citations2012: 141 citations2013: 133 citations2014: 134 citations2015: 169 citations2016: 137 citations2017: 134 citations2018: 167 citations2019: 564 citations2020: 742 citations2021: 1,039 citations2022: 1,012 citations2023: 844 citations2024: 1,454 citations2025: 705 citations2026: 35 citations1980–1990: no citations, so these years are not shown1992–1996: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 3,230 citing papers, 31.9% of this breakdownUnited States: 1,878 citing papers, 18.5% of this breakdownUnited Kingdom: 393 citing papers, 3.9% of this breakdownItaly: 329 citing papers, 3.3% of this breakdownJapan: 317 citing papers, 3.1% of this breakdownGermany: 264 citing papers, 2.6% of this breakdownIndia: 254 citing papers, 2.5% of this breakdownFrance: 250 citing papers, 2.5% of this breakdownSouth Korea: 236 citing papers, 2.3% of this breakdownCanada: 227 citing papers, 2.2% of this breakdownAustralia: 207 citing papers, 2% of this breakdownSpain: 197 citing papers, 2% of this breakdown
0%31.9%Other 23.2%

Fields

  • Medicine45.5%
  • Biochemistry, Genetics and Molecular Biology32.9%
  • Engineering3.9%
  • Materials Science3.7%
  • Agricultural and Biological Sciences3.2%
  • Immunology and Microbiology2.6%
  • Other8.2%

Topics

  • Hepatocellular Carcinoma Treatment and Prognosis7.2%
  • Cholangiocarcinoma and Gallbladder Cancer Studies3.2%
  • Liver Disease Diagnosis and Treatment2.3%
  • DNA Repair Mechanisms1.9%
  • Cancer-related molecular mechanisms research1.6%
  • RNA modifications and cancer1.6%
  • Other82.2%

Coauthors

All papers

Open in search
  1. Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion

    Authors: , , , , , , , , , , , , , , , , - JAMA Oncology 2019 cited by 548

  2. Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Charlotte Zhang, Oulan Li, Rong Guo, Hannah Carter, Jian‐Kang Zhu, Xiaoke Hao, Kang Zhang - Nature Materials 2017 cited by 883

  3. The molecular mechanism of RIG‐I activation and signaling

    Authors: , , , , , - Immunological Reviews 2021 cited by 240

  4. Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shichun Lu, Zheng Lu, Wei‐Fu Lv, Yilei Mao, Guoliang Shao, Ying‐Hong Shi, Tianqiang Song, Guang Tan, Yunqiang Tang, Kaishan Tao, Chidan Wan, Guangyi Wang, Lu Wang, Shunxiang Wang, Tianfu Wen, Baocai Xing, Bang‐De Xiang, Sheng Yan, Dinghua Yang, Guowen Yin, Tao Yin, Zhenyu Yin, Zhengping Yu, Bixiang Zhang, Jialin Zhang, Shuijun Zhang, Ti Zhang, Yamin Zhang, Yubao Zhang, Aibin Zhang, Haitao Zhao, Ledu Zhou, Wu Zhang, Zhenyu Zhu, Shukui Qin, Feng Shen, Xiujun Cai, Gao‐Jun Teng, Jianqiang Cai, Minshan Chen, Qiang Li, Lianxin Liu, Weilin Wang, Tingbo Liang, Jiahong Dong, Xiaoping Chen, Xuehao Wang, Shusen Zheng, Jia Fan - HepatoBiliary Surgery and Nutrition 2022 cited by 198

  5. Faecalibacterium prausnitzii (ATCC 27766) has preventive and therapeutic effects on chronic unpredictable mild stress-induced depression-like and anxiety-like behavior in rats

    Authors: , , , - Psychoneuroendocrinology 2019 cited by 248

  6. Hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin vs. sorafenib for advanced hepatocellular carcinoma

    Authors: , , , , , , , , , , , , , , , , - Journal of Hepatology 2018 cited by 304

  7. Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy versus lenvatinib alone for advanced hepatocellular carcinoma

    Authors: , , , , , , , , , , , , , - Therapeutic Advances in Medical Oncology 2021 cited by 214

  8. Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With FOLFOX in Hepatocellular Carcinoma With Microvascular Invasion: A Multicenter, Phase III, Randomized Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 cited by 169

  9. A novel vascular pattern promotes metastasis of hepatocellular carcinoma in an epithelial–mesenchymal transition–independent manner

    Authors: , , , , , , , , , , , , , - Hepatology 2015 cited by 255

  10. Mesenchymal Stem Cell Exosomes as a New Strategy for the Treatment of Diabetes Complications

    Authors: , , , , - Frontiers in Endocrinology 2021 cited by 117

  11. Integrating spherical video-based virtual reality into elementary school students' scientific inquiry instruction: effects on their problem-solving performance

    Authors: , , , - Interactive Learning Environments, Interact. Learn. Environ. 2019 cited by 141

  12. Hepatic Arterial Infusion Chemotherapy Combined With PD-1 Inhibitors Plus Lenvatinib Versus PD-1 Inhibitors Plus Lenvatinib for Advanced Hepatocellular Carcinoma

    Authors: , , , , , , - Frontiers in Oncology 2021 cited by 125

  13. S5H/DMR6 Encodes a Salicylic Acid 5-Hydroxylase That Fine-Tunes Salicylic Acid Homeostasis

    Authors: , , , , , , , , - PLANT PHYSIOLOGY 2017 cited by 251

  14. Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Zhiqiang Meng, Feng Shen, Jie Shi, Hui‐Chuan Sun, Kaishan Tao, Gao‐Jun Teng, Xuying Wan, Tianfu Wen, Liqun Wu, Jinglin Xia, Mingang Ying, Jian Zhai, Leida Zhang, Xuewen Zhang, Zhiwei Zhang, Haiping Zhao, Donghai Zheng, Xu–Ting Zhi, Jie Zhou, Cuncai Zhou, Jian Zhou, Zhao‐Chong Zeng, Kangshun Zhu, Minshan Chen, Jianqiang Cai, Shuqun Cheng - Liver Cancer 2022 cited by 110

  15. ODC1 Is a Critical Determinant of MYCN Oncogenesis and a Therapeutic Target in Neuroblastoma

    Authors: , , , , , , , , , , , , , , , , , , , , , - Cancer Research 2008 cited by 260

  16. A Prospective Randomized Trial Comparing Percutaneous Local Ablative Therapy and Partial Hepatectomy for Small Hepatocellular Carcinoma

    Authors: , , , , , , , - Annals of Surgery 2006 cited by 1,439

  17. Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety

    Authors: , , , , , , , , , , , - Cancer Communications 2018 cited by 185

  18. Single-cell map of diverse immune phenotypes in the acute myeloid leukemia microenvironment

    Authors: , , , , , , , , , , , , , , , , , , - Biomarker Research 2021 cited by 137

  19. Single-Cell Analysis of Target Antigens of CAR-T Reveals a Potential Landscape of “On-Target, Off-Tumor Toxicity”

    Authors: , , , , , , , , , - Frontiers in Immunology 2021 cited by 88

  20. Radiofrequency Ablation With or Without Transcatheter Arterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Prospective Randomized Trial

    Authors: , , , , , , , , - Journal of Clinical Oncology 2012 cited by 550

  21. LINC02273 drives breast cancer metastasis by epigenetically increasing AGR2 transcription

    Authors: , , , , , , , , , , , , , - Molecular Cancer 2019 cited by 222

  22. Knockdown of hypoxia-inducible factor-1 alpha by tumor targeted delivery of CRISPR/Cas9 system suppressed the metastasis of pancreatic cancer

    Authors: , , , , , , , , , , - Journal of Controlled Release 2019 cited by 126

  23. Chlorin e6-loaded goat milk-derived extracellular vesicles for Cerenkov luminescence-induced photodynamic therapy

    Authors: , , , , , , , , , - European Journal of Nuclear Medicine and Molecular Imaging 2022 cited by 42

  24. Curbing Exosome Communications via Introducing Artificial Membrane Receptors for Metastatic Pancreatic Cancer Therapy

    Authors: , , , , , , - Advanced Materials 2023 cited by 32